PF-00299804
Suppliers
Names
[ CAS No. ]:
1042385-75-0
[ Name ]:
PF-00299804
[Synonym ]:
(2E)-N-{4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl}-4-(1-piperidinyl)-2-butenamide hydrate (1:1)
Dacomitinib [USAN:INN]
2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-, (2E)-, hydrate (1:1)
(2E)-N-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide, hydrate (1:1)
UNII-5092U85G58
2-Butenamide,N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxy-6-quinazolinyl)-4-(1-piperidinyl)-,hydrate (1:1),(2E)
Dacomitinib
dacomitinib hydrate
Dacomitinib hydrate (JAN)
(2E)-N-{4-[(3-chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}-4-(piperidin-1-yl)but-2-enamide monohydrate
Dacomitinib monohydrate
(2E)-N-(4-(3-Chloro-4-fluorophenyl)amino)7-methoxyquinazolin-6-yl)4-(piperidin-1-yl)but-2-enamide monohydrate
PF-00299804
Chemical & Physical Properties
[ Molecular Formula ]:
C24H27ClFN5O3
[ Molecular Weight ]:
487.95
[ Exact Mass ]:
487.178650
[ PSA ]:
92.10000
[ LogP ]:
5.75120
Safety Information
[ Hazard Codes ]:
Xi